News & Events
This just in
Expertise in all things FDA
Menu
Menu
Practices
Industries
FDA Regulatory Categories
Professionals
About Us
Contact Us
FDA Law Blog
News & Events
Search
Twitter
FDA Law Blog
News & Events
Twitter
Page 2 of 19
«
1
2
3
4
5
…
10
…
»
Events
Lisa Baumhardt is speaking at Radiological Society of North America (RSNA) Annual Meeting – Best Practices for AI Model Regulation and Human-AI Collaboration
November 27th, 2023
Ricardo Carvajal is speaking at American Herbal Products Association’s Regulatory Congress
November 14th, 2023
Kurt Karst is speaking at APIIC Plenary Event: Pathway to Build Supply Chain Resilience to Critical Drugs
November 8th, 2023
Sara Koblitz is speaking at Food and Drug Law Journal’s 2023 Symposium: Regulating on Shifting Sands: Analyzing the Impact of Recent and Upcoming Federal Court Decisions on FDA’s Authority
November 8th, 2023
Anne Walsh is speaking at IBA Annual Conference
October 29th, 2023
Sara Koblitz is speaking at ACI’s Paragraph IV Disputes Master Symposium
October 24th, 2023
John Gilbert is speaking at the 2023 National Association of State Controlled Substances Authorities (NASCSA) Conference
October 24th, 2023
Allyson Mullen is speaking at AMDM’s 2023 IVD Hybrid Focus Meeting
October 19th, 2023
John Claud is speaking at ACI’s Forum on Defending FDA-Regulated Consumer Products Class Actions
October 16th, 2023
Kurt Karst and Sara Koblitz are speaking at ACI’s Virtual Course: Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 12th, 2023
Webinar: Clinical Trial Diversity: Understanding and Addressing the Implications of the Food and Drug Omnibus Reform Act of 2022 (“FDORA”);
October 11th, 2023
Webinar: Recent Hospital Controlled Substances Diversion Cases – Cautionary Tales
October 3rd, 2023
Kurt Karst and Sara Koblitz are speaking at GRx + Biosims 2023: Generics and Biosimilars Conference
October 2nd, 2023
Riette van Laack is speaking at ACI’s Legal, Regulatory & Compliance Forum on Cosmetics & Personal Care Products
September 27th, 2023
Kurt Karst is speaking at ACI’s FDA Boot Camp
September 20th, 2023
Ricardo Carvajal is speaking at CHPA Regulatory Scientific & Quality Conference
September 19th, 2023
Faraz Siddiqui is speaking at Medicaid Drug Rebate Program Summit
September 19th, 2023
Riette van Laack is speaking at ACC’s Nutrition Law Symposium
September 8th, 2023
Larry Houck is speaking at the 2023 Opioid Abuse Management Summit
July 20th, 2023
Riette van Laack is speaking at IFT FIRST Short Course: Labeling Requirements and Implications for Food Marketed in the U.S.
July 15th, 2023
Ricardo Carvajal is speaking at ACI’s Legal, Regulatory & Compliance Forum on Dietary Supplements
June 28th, 2023
Charles Raver is speaking at DIA 2023 Global Annual Meeting – ILLUMINATE
June 28th, 2023
James Valentine is speaking at DIA 2023 Global Annual Meeting – ILLUMINATE
June 28th, 2023
Anne Walsh is Co-Chair of the International Bar Association’s World Life Science Conference
June 1st, 2023
HPM Webinar: Demystifying DEA Inspections: Accountability Audits, Mirror Reviews and Mock Inspections
May 24th, 2023
Anne Walsh is speaking at FDLI’s 2023 Annual Conference
May 17th, 2023
Sophia Gaulkin is speaking at Informa Connect’s Drug Pricing Transparency Congress
May 16th, 2023
Jeff Shapiro is speaking at the Florida Medical Device Symposium
May 3rd, 2023
FDA News Webinar: Medical Device Enforcement: Are You Up-to-Date on the Latest Developments
April 20th, 2023
Kurt Karst is speaking at ACI’s Paragraph IV Disputes: Strategies for Brand Name and Generics
April 19th, 2023
Riette Van Laack is speaking at ACI’s Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products Conference
March 28th, 2023
Ricardo Carvajal is a moderator at FDLI’s Food and Dietary Supplement Safety and Regulation Conference (Virtual Event)
March 24th, 2023
Larry Houck is speaking at American Pharmacists Annual Meeting
March 24th, 2023
HPM Webinar: The “End” of the COVID-19 Emergency: the Ryan Haight Act, Telemedicine and Next Steps
March 23rd, 2023
Kurt Karst is Co-Chair of FDA Bootcamp – Training in Core Regulatory Concepts for Life Sciences Attorneys, Business Executives, and Policy Analysts
March 22nd, 2023
Riette Van Laack is speaking at FDLI Introduction to Food Law and Regulation Course
March 22nd, 2023
Ricardo Carvajal is speaking at FDLI Introduction to Food Law and Regulation Course
March 21st, 2023
Doug Farquhar is speaking at Pharma Conference’s Current Hot GMP Topics
February 8th, 2023
Frank Sasinowski will be panelist in Webinar: 2023 Wow! or Yeow!? FDA Outlook for 2023 and Beyond
January 20th, 2023
Anne Walsh is speaking at FDLI’s Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco Industries
December 7th, 2022
Frank Sasinowski is speaking at the Milken Institute Partnering for Patients Forum 2022
December 6th, 2022
Sara Koblitz is speaking at GRx+Bioxims 2022 Generics and Biosimilars Conference
November 8th, 2022
Kurt Karst is speaking at GRx+Biosims 2022 Generics and Biosimilars Conference
November 8th, 2022
Anne Walsh is speaking at International Bar Association Annual Conference
November 3rd, 2022
Sara Koblitz is speaking at Food and Drug Law Journal 2022 Symposium – “The Interconnected Regulatory Landscape: Exploring FDA’s Relationship with Other Domestic Regulators”
November 3rd, 2022
Sara Koblitz is speaking at ACI’s Virtual Series: Hatch-Waxman and BPCIA Passport to Proficiency Series: Focus on Bioequivalence, Exclusivity, Extensions, and Exceptions;
October 25th, 2022
Ricardo Carvajal is speaking at FEMA Fall Symposium
October 24th, 2022
Sara Koblitz is presenting at TOPRA Virtual Masterclass: Module Regulatory Strategy for Established Active Substances
October 13th, 2022
Kurt Karst is speaking at World Intellectual Property Forum
October 10th, 2022
Ricardo Carvajal is speaking at FDLI’s Food Advertising, Labeling, and Litigation Conference: For the Food and Dietary Supplement Industries
September 28th, 2022
Page 2 of 19
«
1
2
3
4
5
…
10
…
»